{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-22-013822","form_type":"8-K","ticker":"PGEN","cik":"0001356090","company_name":"PRECIGEN, INC.","filed_at":"2022-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.498767+00:00","generated_at":"2026-06-24T01:52:25.769185+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Precigen enters $100M ATM equity offering with Cantor Fitzgerald","bullets":["Up to $100M of common stock may be sold at-the-market through Cantor Fitzgerald as agent.","Commission of 3.0% of gross sales price payable to Cantor Fitzgerald.","Proceeds to fund clinical/preclinical development and for working capital and general corporate purposes.","Company has no obligation to sell any shares; may suspend or terminate at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-22-013822","json":"https://secwatch.observer/filing/0000950103-22-013822.json","markdown":"https://secwatch.observer/filing/0000950103-22-013822.md","text":"https://secwatch.observer/filing/0000950103-22-013822.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322013822/0000950103-22-013822-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322013822/dp178412_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T01:52:25.769185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}